ASCO and other stakeholder groups have raised significant concerns regarding the Medicare Part B Drug Demo, citing the proposal's flawed premise, experimental nature, and lack of important patient protections. The society has repeatedly called on the Centers for Medicare & Medicaid Services to withdraw the demo and focus on physician reimbursement reform efforts currently underway.
ASCO in Action regularly provides the latest news and analysis related to cancer policy news; see the following online articles. These updates provide snapshots of ASCO’s ongoing advocacy efforts, as well as opportunities for ASCO members and guests to take action on critical issues affecting the cancer community.
To sign up for advocacy alerts, log in to ASCO.org with your ASCO member or guest account, and visit the subscription center available under your account profile.
The ASCO Research Community Forum held its 2016 Annual Meeting from September 25-26 at ASCO headquarters in Alexandria, Va. Nearly 100 physician investigators and research staff from all types of research sites across the United States attended the meeting.
ASCO Chief Executive Officer Dr. Clifford Hudiis moderated a panel discussion today on Capitol Hill on the National Cancer Moonshot Blue Ribbon Panel Report, where he called on Congress to come together in the upcoming lame duck session to pass a $2 billion appropriations increase for the National Institutes of Health and an additional boost in funding for the NCI to support the Moonshot.
ASCO joined the Congressional Childhood Cancer Caucus for the 7th Annual Childhood Cancer Summit on Capitol Hill. ASCO continues to advocate for the STAR Act, a childhood cancer bill that would identify opportunities to expand research on childhood cancer and therapeutics to treat children with cancer, and increase efforts to improve quality of life.
On September 24, MediaPlanet published its supplement in the Los Angeles Times on the fight against cancer. ASCO President Daniel F. Hayes, MD, FACP, FASCO, penned a foreword discussing President Barack Obama’s Cancer Moonshot Initiative, which is being led by Vice President Joe Biden.
The Hill – a key Capitol Hill publication – posted an op-ed on the harmful Part B Drug Demo jointly authored by ASCO President Daniel F. Hayes, MD, FACP, FASCO, and ASCO Chief Executive Officer Clifford A. Hudis, MD, FACP, FASCO. The op-ed argues that the proposed Medicare Part B Drug Demonstration “would threaten access to high-quality cancer care for millions of Americans living with cancer.”
ASCO presented its “Advocate of the Year Award” to Heather Hylton, MS, PA-C, for her significant contribution during 2015 to advocacy efforts on behalf of individuals living with cancer. The first-ever recipient of the award, Ms. Hylton distinguished herself by tirelessly advancing healthcare policies that will ensure high-quality, high-value cancer care for the more than 1.6 million Americans diagnosed with cancer each year.
Throughout the summer of 2016, ASCO offered the "Are You Ready for MACRA?" Education Series to help oncology practices prepare for the reimbursement and care delivery changes coming under the Medicare Access and CHIP Reauthorization Act, starting Jan. 1, 2017.
ASCO volunteers came to Capitol Hill for the first annual “ASCO Advocacy Summit” to urge Congress to take action on critical policies that would advance cancer research and treatment, and ensure that the 14.5 million patients and survivors of cancer have access to high-quality, high-value health care.
On Sept. 21, the Journal of Global Oncology published the article “Quality Oncology Practice Initiative Can Guide and Improve Oncology Providers’ Training in Brazil,” which outlines a study showing how ASCO’s Quality Oncology Practice Initiative (QOPI®) measures were used to examine the care of patients with breast, colorectal, lymphoma, gynecology, and lung cancers at Brazilian public university hospital.
On Sept. 21, the Journal of Global Oncology published the article “QOPI International, or How to Globalize Quality?” which discusses the Contemporary Oncology Team of Athens at Hygeia Hospital’s experience using ASCO’s Quality Oncology Practice Initiative (QOPI®) and becoming the first international QOPI-certified practice.
ASCO presents the first-ever ASCO Congressional Leadership Award to Representative Michael Burgess, MD (TX-26) to recognize his steadfast work to support policies related to cancer research and treatment.
ASCO joined a diverse group of close to 90 stakeholder organizations in calling on the Centers for Medicare & Medicaid Services (CMS) to rescind reimbursement cuts for certain lung cancer screening codes in the agency's proposed rule on the 2017 Hospital Outpatient Prospective Payment System by retaining current reimbursement rates as established in the 2016 HOPPS final rule.
A recent blog post by Andrew Slavitt, acting administrator of the Centers for Medicare & Medicaid Services (CMS), outlined four options that will allow providers to select the pace at which they implement the Medicare Access and CHIP Reauthorization Act in their practices in 2017.
ASCO Chief Medical Officer Richard L. Schilsky, MD, FASCO, FACP, published a blog post on Diagnosis: Cancer on the link between obesity and cancer. The blog post highlights a study which showed that being overweight or obese increases a person’s risk for developing at least 13 different types of cancer.